158 related articles for article (PubMed ID: 2576995)
1. The epidermal growth factor receptor and its ligands.
Wells A
Cancer Treat Res; 1989; 47():143-68. PubMed ID: 2576995
[No Abstract] [Full Text] [Related]
2. Deletion-mutant epidermal growth factor receptor in human gliomas: effects of type II mutation on receptor function.
Humphrey PA; Gangarosa LM; Wong AJ; Archer GE; Lund-Johansen M; Bjerkvig R; Laerum OD; Friedman HS; Bigner DD
Biochem Biophys Res Commun; 1991 Aug; 178(3):1413-20. PubMed ID: 1678600
[TBL] [Abstract][Full Text] [Related]
3. The type 1 (EGFR-related) family of growth factor receptors and their ligands.
Prigent SA; Lemoine NR
Prog Growth Factor Res; 1992; 4(1):1-24. PubMed ID: 1355372
[TBL] [Abstract][Full Text] [Related]
4. An oncogenic point mutation confers high affinity ligand binding to the neu receptor. Implications for the generation of site heterogeneity.
Ben-Levy R; Peles E; Goldman-Michael R; Yarden Y
J Biol Chem; 1992 Aug; 267(24):17304-13. PubMed ID: 1355090
[TBL] [Abstract][Full Text] [Related]
5. Cloning, expression, and biological effects of erbB-2/neu gene in mammalian cells.
Di Fiore PP; Segatto O; Aaronson SA
Methods Enzymol; 1991; 198():272-7. PubMed ID: 1677443
[No Abstract] [Full Text] [Related]
6. p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity.
Stern DF; Heffernan PA; Weinberg RA
Mol Cell Biol; 1986 May; 6(5):1729-40. PubMed ID: 2878363
[TBL] [Abstract][Full Text] [Related]
7. Receptor functions and ligand-dependent transforming potential of a chimeric kit proto-oncogene.
Lev S; Yarden Y; Givol D
Mol Cell Biol; 1990 Nov; 10(11):6064-8. PubMed ID: 1700279
[TBL] [Abstract][Full Text] [Related]
8. A chimeric EGFR/neu receptor in studies of neu function.
Lehtola L; Lehväslaiho H; Koskinen P; Alitalo K
Cancer Treat Res; 1992; 61():213-28. PubMed ID: 1360234
[No Abstract] [Full Text] [Related]
9. Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer.
Lemoine NR; Jain S; Silvestre F; Lopes C; Hughes CM; McLelland E; Gullick WJ; Filipe MI
Br J Cancer; 1991 Jul; 64(1):79-83. PubMed ID: 1677259
[No Abstract] [Full Text] [Related]
10. Mechanisms involving an expanding erbB/EGF receptor family of tyrosine kinases in human neoplasia.
Di Fiore PP; Kraus MH
Cancer Treat Res; 1992; 61():139-60. PubMed ID: 1360229
[No Abstract] [Full Text] [Related]
11. Viral oncogenes, v-yes and v-erbB, and their cellular counterparts.
Toyoshima K; Yamamoto T; Kawai S; Yoshida M
Adv Virus Res; 1987; 32():97-127. PubMed ID: 3303862
[No Abstract] [Full Text] [Related]
12. Tissue-specific transformation by epidermal growth factor receptor: a single point mutation within the ATP-binding pocket of the erbB product increases its intrinsic kinase activity and activates its sarcomagenic potential.
Shu HK; Pelley RJ; Kung HJ
Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9103-7. PubMed ID: 1979168
[TBL] [Abstract][Full Text] [Related]
13. A single amino acid substitution is sufficient to modify the mitogenic properties of the epidermal growth factor receptor to resemble that of gp185erbB-2.
Di Fiore PP; Helin K; Kraus MH; Pierce JH; Artrip J; Segatto O; Bottaro DP
EMBO J; 1992 Nov; 11(11):3927-33. PubMed ID: 1356764
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors.
Kraus MH; Issing W; Miki T; Popescu NC; Aaronson SA
Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9193-7. PubMed ID: 2687875
[TBL] [Abstract][Full Text] [Related]
15. Mitogenic activation of the Ras guanine nucleotide exchange factor in NIH 3T3 cells involves protein tyrosine phosphorylation.
Li BQ; Subleski M; Shalloway D; Kung HF; Kamata T
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8504-8. PubMed ID: 8104337
[TBL] [Abstract][Full Text] [Related]
16. Neu and its ligands: from an oncogene to neural factors.
Peles E; Yarden Y
Bioessays; 1993 Dec; 15(12):815-24. PubMed ID: 7908191
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.
Kokai Y; Dobashi K; Weiner DB; Myers JN; Nowell PC; Greene MI
Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5389-93. PubMed ID: 2899889
[TBL] [Abstract][Full Text] [Related]
18. Functional heterogeneity of proto-oncogene tyrosine kinases: the C terminus of the human epidermal growth factor receptor facilitates cell proliferation.
Velu TJ; Vass WC; Lowy DR; Beguinot L
Mol Cell Biol; 1989 Apr; 9(4):1772-8. PubMed ID: 2786142
[TBL] [Abstract][Full Text] [Related]
19. Oncogenes related to growth factor receptors.
Toyoshima K
Acta Neurochir Suppl (Wien); 1987; 41():110-7. PubMed ID: 2833073
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of ligand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells.
Kraus MH; Fedi P; Starks V; Muraro R; Aaronson SA
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2900-4. PubMed ID: 8464905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
